英聯股份(002846.SZ):取得4項實用新型專利證書
格隆匯12月28日丨英聯股份(002846.SZ)公佈,公司和全資子公司英聯金屬科技(汕頭)有限公司(“汕頭英聯”)於近日取得中華人民共和國國家知識產權局頒發的4項實用新型專利證書,分別為高強度耐高壓易開啟的寬面鋁質易開蓋,耐高温殺菌的罐頭易撕蓋,拉環強化結構及易拉蓋,拉環製造模具及裝置。
上述實用新型專利為公司及子公司自主研發取得,其所涉及的技術及應用領域與公司主要產品相關。
上述專利的取得是公司重要核心技術的體現和延伸,不會對公司及子公司生產經營產生重大影響,但有利於公司及子公司進一步完善知識產權保護體系,發揮自主知識產權優勢,促進技術創新,提高公司及子公司的綜合競爭能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.